Ronald E. Stenkamp

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

The prominent role of the CD40 receptor in B cell responses led us to investigate the role of the gp39-CD40 interaction in a group of primary immunodeficient patients with defective antibody production. Here we report that patients with hyper-IgM syndrome (HIM) have a defective gp39-CD40 interaction. B cells from HIM patients express functional CD40, but their T cells do not bind CD40-Ig. These patients expressed normal levels of gp39 mRNA, but these mRNAs encode defective gp39 proteins owing to mutations in the extracellular domain of gp39. Soluble recombinant forms of gp39 containing these mutations were unable to bind CD40 and drive normal B cell proliferation. The gene encoding gp39 was mapped to Xq26, the X chromosome region where the gene responsible for HIM had previously been mapped. These data suggest that a defect in gp39 is the basis of X-linked HIM.

Crystal structure of a photoactivated deprotonated intermediate of rhodopsin

The changes that lead to activation of G protein-coupled receptors have not been elucidated at the structural level. In this work we report the crystal structures of both ground state and a photoactivated deprotonated intermediate of bovine rhodopsin at a resolution of 4.15 Å. In the photoactivated state, the Schiff base linking the chromophore and Lys-296 becomes deprotonated, reminiscent of the G protein-activating state, metarhodopsin II. The structures reveal that the changes that accompany photoactivation are smaller than previously predicted for the metarhodopsin II state and include changes on the cytoplasmic surface of rhodopsin that possibly enable the coupling to its cognate G protein, transducin. Furthermore, rhodopsin forms a potentially physiologically relevant dimer interface that involves helices I, II, and 8, and when taken with the prior work that implicates helices IV and V as the physiological dimer interface may account for one of the interfaces of the oligomeric structure of rhodopsin seen in the membrane by atomic force microscopy. The activation and oligomerization models likely extend to the majority of other G protein-coupled receptors.

A crystallographic model for azurin at 3 Å resolution

Abstract The structure of the blue copper protein azurin (Mr 14,000) from Pseudomonas aeruginosa has been determined from a 3.0 A resolution electron density map computed with phases based on a uranyl derivative to 3 A resolution and a platinum derivative to 3.7 A. Interpretation of the somewhat noisy map was based on comparison of the density of the four molecules in the asymmetric unit with their averaged density. The polypeptide chain folds into an eight-strand β barrel with an additional flap containing a short helix. The copper atom is bound at one end and on the inside of the barrel, probably to a cysteine, a methionine, and two histidine residues.

Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen

Abstract Background: Blood coagulation occurs by a cascade of zymogen activation resulting from minor proteolysis. The final stage of coagulation involves thrombin generation and limited proteolysis of fibrinogen to give spontaneously polymerizing fibrin. The resulting fibrin network is covalently crosslinked by factor XIIIa to yield a stable blood clot. Fibrinogen is a 340 kDa glycoprotein composed of six polypeptide chains, ( α β γ ) 2 , held together by 29 disulfide bonds. The globular C terminus of the γ chain contains a fibrin-polymerization surface, the principal factor XIIIa crosslinking site, the platelet receptor recognition site, and a calcium-binding site. Structural information on this domain should thus prove helpful in understanding clot formation. Results: The X-ray crystallographic structure of the 30 kDa globular C terminus of the γ chain of human fibrinogen has been determined in one crystal form using multiple isomorphous replacement methods. The refined coordinates were used to solve the structure in two more crystal forms by molecular replacement; the crystal structures have been refined against diffraction data to either 2.5 A or 2.1 A resolution. Three domains were identified in the structure, including a C-terminal fibrin-polymerization domain (P), which contains a single calcium-binding site and a deep binding pocket that provides the polymerization surface. The overall structure has a pronounced dipole moment, and the C-terminal residues appear highly flexible. Conclusions: The polymerization domain in the γ chain is the most variable among a family of fibrinogen-related proteins and contains many acidic residues. These residues contribute to the molecular dipole moment in the structure, which may allow electrostatic steering to guide the alignment of fibrin monomers during the polymerization process. The flexibility of the C-terminal residues, which contain one of the factor XIIIa crosslinking sites and the platelet receptor recognition site, may be important in the function of this domain.

Structural Basis for Mechanical Force Regulation of the Adhesin FimH via Finger Trap-like β Sheet Twisting

The Escherichia coli fimbrial adhesive protein, FimH, mediates shear-dependent binding to mannosylated surfaces via force-enhanced allosteric catch bonds, but the underlying structural mechanism was previously unknown. Here we present the crystal structure of FimH incorporated into the multiprotein fimbrial tip, where the anchoring (pilin) domain of FimH interacts with the mannose-binding (lectin) domain and causes a twist in the beta sandwich fold of the latter. This loosens the mannose-binding pocket on the opposite end of the lectin domain, resulting in an inactive low-affinity state of the adhesin. The autoinhibition effect of the pilin domain is removed by application of tensile force across the bond, which separates the domains and causes the lectin domain to untwist and clamp tightly around the ligand like a finger-trap toy. Thus, beta sandwich domains, which are common in multidomain proteins exposed to tensile force in vivo, can undergo drastic allosteric changes and be subjected to mechanical regulation.

Structures of deoxy and oxy hemerythrin at 2.0 A resolution.

The crystallographic structure analyses of deoxy and oxy hemerythrin have been carried out at 2.0 A resolution to extend the low resolution views of the physiological forms of this oxygen-binding protein. Restrained least-squares refinement has produced molecular models giving R-values of 16.8% for deoxy (41,064 reflections from 10 A to 2.0 A) and 17.3% for oxy hemerythrin (40,413 reflections from 10.0 A to 2.0 A). The protein structure in each derivative is very similar to that of myohemerythrin and the various met forms of hemerythrin. The binuclear complex in each derivative retains an oxygen atom bridging the two iron atoms, but the bond lengths found in deoxy hemerythrin support the idea that, in that form, the bridge is protonated, i.e. the bridging group is a hydroxyl. Dioxygen binds to the pentaco-ordinate iron atom in deoxy hemerythrin in the conversion to oxy hemerythrin. The interatomic distances are consistent with the proposed mechanism where the proton from the bridging group is transferred to the bound dioxygen, stabilizing it in the peroxo oxidation state by forming a hydrogen bond between the peroxy group and the bridging oxygen atom.

Functional and structural characterization of rhodopsin oligomers

A major question in G protein-coupled receptor signaling concerns the quaternary structure required for signal transduction. Do these transmembrane receptors function as monomers, dimers, or larger oligomers? We have investigated the oligomeric state of the model G protein-coupled receptor rhodopsin (Rho), which absorbs light and initiates a phototransduction-signaling cascade that forms the basis of vision. In this study, different forms of Rho were isolated using gel filtration techniques in mild detergents, including n-dodecyl-β-d-maltoside, n-tetradecyl-β-d-maltoside, and n-hexadecyl-β-d-maltoside. The quaternary structure of isolated Rho was determined by transmission electron microscopy, demonstrating that in micelles containing n-dodecyl-β-d-maltoside, Rho exists as a mixture of monomers and dimers whereas in n-tetradecyl-β-d-maltoside and n-hexadecyl-β-d-maltoside Rho forms higher ordered structures. Especially in n-hexadecyl-β-d-maltoside, most of the particles are present in tightly packed rows of dimers. The oligomerization of Rho seems to be important for interaction with its cognate G protein, transducin. Although the activated Rho (Meta II) monomer or dimers are capable of activating the G protein, transducin, the activation process is much faster when Rho exists as organized dimers. Our studies provide direct comparisons between signaling properties of Meta II in different quaternary complexes.

Sequencing a protein by x-ray crystallography. II. Refinement of yeast hexokinase B co-ordinates and sequence at 2.1 A resolution.

Although the amino acid sequence of yeast hexokinase B has not been determined by chemical means, crystallographic refinement of the hexokinase monomer was carried out at 2.1 A resolution to improve both the atomic co-ordinates and the amino acid sequence, which had been obtained from a 2.5 A electron density map. The atomic co-ordinates were adjusted by real-space refinement into a multiple isomorphous replacement map, followed by automated difference Fourier refinement, and restrained parameter structure factor least-squares refinement. The amino acid sequence was altered periodically after visual inspection of (Fo − Fc) difference electron density maps. Evidence of the improvement in the amino acid sequence was provided by the better agreement between the X-ray and chemically derived amino acid compositions, and most importantly by the ability to locate two short peptides which had been chemically sequenced. While only 6 out of the 18 residues in these two peptides agree with the sequence of the original model, 12 residues agree with the sequence of the refined model and the others differ by only an atom or two. The refined model contains 3293 of of the 3596 non-hydrogen atoms expected from the amino acid composition and 152 bound water molecules. The crystallographic R factor at 2.1 A is 0.25. We show that there are several advantages to refining the structure of even a protein of unknown sequence. (1) Improved phases can be obtained to the resolution limit of the diffraction pattern starting with a model derived from a 2.5 A map. (2) The accuracy of the amino acid sequence derived by X-ray methods alone can be substantially improved. (3) Functionally important residues can be identified before chemical sequence information is available. (4) The improved X-ray sequence should greatly reduce the effort required to obtain a chemical sequence; since peptides as short as eight or nine residues can be located in the refined X-ray sequence, peptides do not need to be overlapped by chemical means.

X‐Ray Structure and Designed Evolution of an Artificial Transfer Hydrogenase

A structure is worth a thousand words: guided by the crystal structure of an S-selective artificial transfer hydrogenase, designed evolution was used to optimize the selectivity of hybrid catalysts. Fine-tuning of the second coordination sphere of the ruthenium center by introduction of two point mutations allowed the identification of selective artificial transfer hydrogenases for the redn. of dialkyl ketones.

A refined model of the sugar binding site of yeast hexokinase B

Abstract The sugar binding site of monomeric yeast hexokinase B complexed with the competitive inhibitor o -toluoylglucosamine has been examined in the model resulting from a crystallographic refinement at 2·1 A resolution. Difference Fourier maps calculated assuming various sugar configurations demonstrate that the o -toluoylglucosamine binds in the chair equatorial conformation with its 1-hydroxyl axial (α-anomer). The absence of a chemically derived amino acid sequence has complicated our interpretations of sugar-enzyme interactions. Nevertheless, we conclude that the carboxyl group of Asp189 is hydrogen-bonded to both the 6- and 4-hydroxyl groups. The 4-hydroxyl group is hydrogen-bonded also to Asx188 and Asx215, while the 3-hydroxyl is interacting with both Asx245 and Asx 188, consistent with the enzymes observed sugar specificity. The carboxyl group of Asp 189 is excluded from solvent in the presence of glucose and may be acting as a general base to enhance the nucleophilicity of the 6-hydroxyl group and thereby promote its attack on the γ-phosphate of ATP. Glucose is shown to bind to the enzyme in the same orientation and conformation as the sugar moiety of o -toluoylglucosamine, so that the 6-hydroxyl group and the carboxyl of Asp 189 are in identical positions in complexes with these two sugars. The fact that o -toluoylglucosamine is not a substrate must be explained by two observations. First, the binding of glucose results in one lobe rotating by 12 ° relative to the other lobe, thereby closing off the slit into which the sugar has bound (Bennett & Steitz, unpublished results). Second, o -toluoylglucosamine does not produce this conformational change, because the bulky toluoyl group prevents the closing of this slit between the two lobes. We conclude, therefore, that the large glucose-induced conformational change must be essential for subsequent catalytic steps. It appears unlikely from this study that thiols play any direct role in catalysis or in substrate binding. One thiol group, however, lies 5·5 A from the 3-hydroxyl and is hydrogen-bonded to three of the Asx groups that are binding the sugar. Chemical modification of this buried thiol would disrupt the glucose binding site, which could account for the observation (Otieno et al. , 1977) that cyanylation of one of the enzymes thiols abolishes enzymatic activity. A sulfate molecule is bound to the enzyme by two serine side-chains and its sulfur atom is 5·5 A from the 6-hydroxyl group of glucose. If the γ-phosphate of ATP binds to this sulfate binding site, it would still be a little too far from the 6-hydroxyl for direct phosphoryl transfer.